• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑癌基因 ARMC5 通过 NRF1 周转控制肾上腺的氧化还原状态。

Tumor suppressor gene ARMC5 controls adrenal redox state through NRF1 turnover.

机构信息

Université de Paris, Institut Cochin, INSERM, CNRS, Paris, France.

Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.

出版信息

Endocr Relat Cancer. 2022 Sep 30;29(11):615-624. doi: 10.1530/ERC-22-0099. Print 2022 Nov 1.

DOI:10.1530/ERC-22-0099
PMID:36040830
Abstract

is a tumor suppressor gene frequently mutated in primary bilateral macronodular adrenal hyperplasia (PBMAH), an adrenal cause of Cushing's syndrome. The function of ARMC5 is poorly understood, aside from the fact that it regulates cell viability and adrenal steroidogenesis by mechanisms still unknown. Tumor suppressor genes play an important role in modifying intracellular redox response, which in turn regulates diverse cell signaling pathways. In this study, we demonstrated that inactivation in adrenocortical cells increased the expression of actors scavenging reactive oxygen species, such as superoxide dismutases (SOD) and peroxiredoxins (PRDX) by increasing the transcriptional regulator NRF1. Moreover, ARMC5 is involved in the NRF1 ubiquitination and in its half-life. Finally, inactivation alters adrenocortical steroidogenesis through the activation of p38 pathway and decreases cell sensitivity to ferroptosis participation to increase cell viability. Altogether, this study uncovers a function of ARMC5 as a regulator of redox homeostasis in adrenocortical cells, controlling steroidogenesis and cell survival.

摘要

是一种肿瘤抑制基因,常发生突变于双侧巨结节性肾上腺增生症(PBMAH),即库欣综合征的肾上腺病因。ARMC5 的功能除了通过尚不清楚的机制调节细胞活力和肾上腺类固醇生成外,了解甚少。肿瘤抑制基因在调节细胞内氧化还原反应中发挥着重要作用,而细胞内氧化还原反应又反过来调节多种细胞信号通路。在这项研究中,我们证明了在肾上腺皮质细胞中失活会通过增加转录调节因子 NRF1 的表达,来增加清除活性氧的因子(如超氧化物歧化酶[SOD]和过氧化物酶[PRDX])的表达。此外,ARMC5 参与 NRF1 的泛素化及其半衰期。最后,失活通过激活 p38 通路改变肾上腺皮质类固醇生成,并降低细胞对铁死亡的敏感性,从而增加细胞活力。总之,这项研究揭示了 ARMC5 作为肾上腺皮质细胞氧化还原平衡调节剂的功能,控制类固醇生成和细胞存活。

相似文献

1
Tumor suppressor gene ARMC5 controls adrenal redox state through NRF1 turnover.抑癌基因 ARMC5 通过 NRF1 周转控制肾上腺的氧化还原状态。
Endocr Relat Cancer. 2022 Sep 30;29(11):615-624. doi: 10.1530/ERC-22-0099. Print 2022 Nov 1.
2
A novel pathogenic variant of ARMC5 in a patient with primary bilateral macronodular adrenal hyperplasia: a case report.ARMC5 基因的一种新的致病性变异在原发性双侧巨结节性肾上腺增生患者中的作用:病例报告。
BMC Endocr Disord. 2022 Aug 22;22(1):211. doi: 10.1186/s12902-022-01128-x.
3
ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.ARMC5 突变与库欣综合征的大结节性肾上腺增生。
N Engl J Med. 2013 Nov 28;369(22):2105-14. doi: 10.1056/NEJMoa1304603.
4
Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations.双侧原发性巨结节性肾上腺皮质增生(PBMAH)伴 ARMC5 突变患者。
BMC Endocr Disord. 2023 Apr 7;23(1):77. doi: 10.1186/s12902-023-01324-3.
5
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.原发性双侧大结节性肾上腺增生患者中ARMC5突变患病率的多中心研究:从基因特征到临床表型
Endocrine. 2017 Mar;55(3):959-968. doi: 10.1007/s12020-016-0956-z. Epub 2016 Apr 19.
6
High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia.肾上腺 P450 芳香化酶(CYP19A1)高表达与 ARMC5-原发性双侧大结节性肾上腺皮质增生相关。
J Steroid Biochem Mol Biol. 2019 Jul;191:105316. doi: 10.1016/j.jsbmb.2019.02.011. Epub 2019 Apr 20.
7
ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.一大群原发性大结节性肾上腺增生患者中的 ARMC5 突变:临床及功能后果
J Clin Endocrinol Metab. 2015 Jun;100(6):E926-35. doi: 10.1210/jc.2014-4204. Epub 2015 Apr 8.
8
[Hereditary Cushing's syndrome caused by primary bilateral macronodular adrenal hyperplasia due to ARMC5 mutation with concomitant primary hyperparathyroidism: the first known case in Russia].[ARMC5突变所致原发性双侧大结节性肾上腺增生伴发原发性甲状旁腺功能亢进引起的遗传性库欣综合征:俄罗斯首例报道]
Probl Endokrinol (Mosk). 2019 Jun 30;65(2):89-94. doi: 10.14341/probl9712.
9
The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH).在原发性大结节性肾上腺皮质增生症(PMAH)结节的人类细胞培养物中 ARMC5 的作用。
Mol Cell Endocrinol. 2018 Jan 15;460:36-46. doi: 10.1016/j.mce.2017.06.027. Epub 2017 Jul 1.
10
Extensive ARMC5 genetic variance in primary bilateral macronodular adrenal hyperplasia that started with exophthalmos: a case report.以突眼起病的原发性双侧大结节性肾上腺增生中的广泛ARMC5基因变异:一例报告
J Med Case Rep. 2018 Jan 18;12(1):13. doi: 10.1186/s13256-017-1529-3.

引用本文的文献

1
Adrenal insufficiency in inborn errors of metabolism and vice versa: Case reports and review of the literature.先天性代谢缺陷中的肾上腺功能不全及反之亦然:病例报告与文献综述
Mol Genet Metab Rep. 2025 May 26;43:101232. doi: 10.1016/j.ymgmr.2025.101232. eCollection 2025 Jun.
2
ARMC5 mutations in primary bilateral macronodular adrenal hyperplasia: a family case report.原发性双侧大结节性肾上腺增生中的 ARMC5 突变:一例家族病例报告
BMC Med Genomics. 2025 Mar 10;18(1):44. doi: 10.1186/s12920-025-02112-9.
3
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update.
原发性双侧大结节性肾上腺增生中ARMC5的突变图谱:最新进展
Orphanet J Rare Dis. 2025 Feb 5;20(1):51. doi: 10.1186/s13023-025-03554-1.
4
Cushing syndrome.库欣综合征
Nat Rev Dis Primers. 2025 Jan 23;11(1):4. doi: 10.1038/s41572-024-00588-w.
5
Molecular and Genetics Perspectives on Primary Adrenocortical Hyperfunction Disorders.原发性肾上腺皮质功能亢进症的分子遗传学研究进展
Int J Mol Sci. 2024 Oct 22;25(21):11341. doi: 10.3390/ijms252111341.
6
ARMC5 selectively degrades SCAP-free SREBF1 and is essential for fatty acid desaturation in adipocytes.ARMC5选择性降解无SCAP的SREBF1,对脂肪细胞中的脂肪酸去饱和作用至关重要。
J Biol Chem. 2024 Dec;300(12):107953. doi: 10.1016/j.jbc.2024.107953. Epub 2024 Nov 2.
7
Knockdown of CPSF4 Inhibits Bladder Cancer Cell Growth by Upregulating NRF1.敲低CPSF4通过上调NRF1抑制膀胱癌细胞生长。
Biochem Genet. 2024 Jul 22. doi: 10.1007/s10528-024-10891-6.
8
FHOD1 is upregulated in glioma cells and attenuates ferroptosis of glioma cells by targeting HSPB1 signaling.FHOD1 在神经胶质瘤细胞中上调,并通过靶向 HSPB1 信号通路来减弱神经胶质瘤细胞的铁死亡。
CNS Neurosci Ther. 2023 Nov;29(11):3351-3363. doi: 10.1111/cns.14264. Epub 2023 May 21.